If you purchased, paid, and/or provided reimbursement for some or all of the purchase price of Seroquel XR or quetiapine fumarate ER 50 mg, 150 mg, 200 mg, and/or 300 mg tablets, you could get money from class action settlements.
Proposed settlements have been reached in a class action lawsuit against AstraZeneca Pharmaceuticals LP and AstraZeneca UK Limited (collectively, “AstraZeneca”) and Handa Pharmaceuticals, LLC (“Handa”) (together with AstraZeneca, “Defendants”). The lawsuit alleges that AstraZeneca and Handa unlawfully kept 50 mg, 150 mg, 200 mg, and 300 mg strengths of generic quetiapine fumarate ER (i.e., generic versions of Seroquel XR) off the market so third-party payors paid more for brand Seroquel XR and generic quetiapine fumarate ER than they should have. AstraZeneca and Handa deny that they did anything wrong.
There have been separate settlements with AstraZeneca and Handa. This website concerns both settlements.
A $5.475 million Settlement Fund will pay (1) money to eligible Settlement Class Members; (2) notice and administration costs; (3) service awards to the class representatives who brought the lawsuit; and (4) attorneys’ fees, costs, and expenses.
These rights and options—and the deadlines to exercise them—are explained in the Notice and on the Frequently Asked Questions (FAQ) page of this website. The Court in charge of this case still must decide whether to approve the settlement. Payments will be made to those who qualify only after the Court approves the settlement and any appeals are resolved. Please be patient.